TrialThe Lancet. Global health2025

Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: a phase 3b, prospective, open-label, non-randomised, cohort study.

Victor Kande Betu Kumeso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.